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Summary
Objective: For autologous chondrocyte transplantation (ACT) chondrocytes are expanded in vitro. During expansion these cells may
dedifferentiate. This change in phenotype is characterized by a raised expression of type I collagen and a decrease in type II collagen
expression. Since high expression of type II collagen is of central importance for the properties of hyaline cartilage, we investigated if the
growth factor bone morphogenetic protein-2 (BMP-2) may modulate the chondrogenic phenotype in monolayer cell cultures and in three-
dimensional culture systems.
Design: Chondrocytes from articular knee cartilage of 11 individuals (average age: 39.8 years) with no history of joint disease were isolated and
seeded either in monolayer cultures or embedded in alginate beads in presence or absence of human recombinant BMP-2 (hr-BMP-2). Then,
cells were harvested and analysis of the chondrogenic phenotypewas performed using quantitative RT-PCR, immunocytochemistry and ELISA.
Results: Addition of BMP-2 to chondrocytes expanded in two-dimensional (2D) cultures during the ﬁrst subculture (P1) had no effect on
mRNA amounts encoding type II collagen and interleukin-1b (IL-1b). In contrast, seeding chondrocytes in three-dimensional (3D) alginate
cultures raised type II collagen expression signiﬁcantly and addition of BMP-2 enhanced this effect.
Conclusions: We conclude that chondrocytes during expansion for ACT may beneﬁt from BMP-2 activation only when seeded in an
appropriate 3D culture system.
 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





Full thickness chondral defects in human adult articular
cartilage have been a major problem for orthopaedic
surgeons and is still challenging because of its poor self-
healing capacity1. The presence of isolated injuries in an
articular cartilage is a well known risk factor for more
extensive joint damage, which untreated may result in early
osteoarthritis (OA). To prevent this evolution, several
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sponse techniques (drilling or microfracture), osteochondral
transplantation (OCT or ‘‘mosaicplasty’’) as well as the
transplantation of periosteum and perichondrium in order to
provide a resurfacing of the damaged cartilage surface2. In
1994, Brittberg and colleagues reported the ﬁrst clinical
results of transplantation of human autologous chondro-
cytes cultured in a monolayer system in vitro3. Autologous
chondrocytes transplantation (ACT) is suitable even for
large joint defects and may result in better cartilage repair,
concerning clinical outcome as well as histology of the
repair tissue, when compared to other techniques4,5.
Autologous chondrocytes are prepared from a cartilage
biopsy arthroscopically obtained from a less-weight bearing
area of the joint and expanded in vitro. In a second open
knee surgery, the expanded cells are injected into the
cartilage defect, which was watertight covered before with
a periosteal ﬂap3. However, although such surgeries were
applied successfully for more than a decade now, sequela
of a wide arthrotomy represent the major disadvantage of
this technique and therefore methods to seed the chon-
drocytes onto scaffolds to be ﬁxed into the defect by
arthroscopic or at least minimally invasive techniques are
under investigation.
560 T. Gru¨nder et al.: BMP-2 enhancement studiesFurther, cartilage is a tissue rich in extracellular matrix with
few chondrocytes interspersed. Consequently, the yield of
chondrocytes which can be harvested from small biopsies is
very limited. To achieve the required amount of cells needed
for the defect, chondrocytes must undergo several popula-
tion doublings in vitro, which strictly correlateswith a dramatic
loss of the chondrogenic phenotype. Chondrocytes grown in
monolayer culture undergo a characteristic process of
dedifferentiation, marked by a loss of type II collagen and
aggrecan expression and the induction of type I collagen
expression. Dedifferentiated chondrocytes do not re-differ-
entiate sufﬁciently after several population doublings of in
vitro culture6. In contrast, systems that support the rounded
cell morphology may maintain the differentiated chondro-
genic phenotype7,8. The proliferation rate of chondrocytes is
decreased under these conditions when compared to
monolayer cultures. For this reason, a suitable compromise
has to be found between cell proliferation rates required for
e.g., ACT and the degree of differentiation tolerable for tissue
engineering of articular cartilage.
Therefore we tested the re-differentiation potential of
chondrocyte cultures in alginate beads in presence of bone
morphogenetic protein-2 (BMP-2). The BMP-2 is a member
of the TGF-b superfamily and has been shown to play a role
in chondrocyte differentiation and matrix maturation. BMP-2
is known to prevent dedifferentiation of chondrocytes grown
in monolayer cultures9e11. However, the effect on the
chondrogenic phenotype of human recombinant BMP-2 (hr-
BMP-2) on human chondrocytes cultured in monolayer and
alginate beads has been less characterized. Speciﬁcally,
the effect of growth factor-supplemented cell culture media
on the expression of inﬂammatory cytokines such as
interleukin-1b (IL-1b) and IL-18 are still unclear. Therefore
we applied BMP-2 to human articular chondrocytes cultured
in monolayer and in alginate beads, and investigated the
metabolic effects monitoring messenger RNA (mRNA)
levels for marker genes required for cartilage regeneration
after ACT and levels of inﬂammatory cytokines by quanti-
tative polymerase chain reaction (RT-PCR).
Materials and methods
PREPARATION OF HUMAN CHONDROCYTES
Articular knee cartilage from 11 human donors (4 females
and 7 males; average age: 39.8 years; min: 19; max: 77),
with no history of inﬂammatory joint disease and without
known infectious disease, was obtained from the local
trauma surgery hospital according to their protocols. The
study was approved by the local ethics committee (Medical
Faculty of the University of Tu¨bingen). Cartilage appeared
macroscopically normal and free of osteoarthritic lesions in
all biopsies included. Cells from each patient’s tissue were
isolated, cultured and treated separately. Cartilage samples
were ﬁrst washed twice in a phosphate buffer solution
(PBS; BioWhittaker, Verviers, Belgium) and then minced.
Extracellular matrix was digested overnight at 37(C by
incubation of the tissue in 2.5 mg/ml type II collagenase
(Roche, Mannheim, Germany) in Dulbecco modiﬁed Eagle
medium (DMEM/Ham’s F12; BioWhittaker, Verviers, Bel-
gium) containing 5% human serum.
PROLIFERATION OF CHONDROCYTES IN PRIMARY CULTURES
Isolated chondrocytes were resuspended by pipetting
several times and ﬁltered through a 100 mm ﬁlter to remove
undigested cartilage fragments and extracellular matrixremnants. After centrifugation the cells were resuspended
in DMEM/F12 (2:1) cell culture medium supplemented with
10% human serum. Chondrocytes were seeded as primary
cell culture in 75 cm2 culture ﬂasks (BD Falcon; Heidel-
berg, Germany) at low density (5! 103 cells/cm2) and
cultured without any antibiotics at 37(C in a humidiﬁed
atmosphere containing 5% CO2. At conﬂuency the primary
cell cultures were harvested using trypsineEDTA (Bio-
Whittaker; Verviers, Belgium) and passaged.
RE-SEEDING CELLS IN MONOLAYER
1.5! 106 passaged cells were seeded in four 75 cm2
culture ﬂasks. Cells were cultured with DMEM/F12 (2:1) cell
culture medium with 10% human serum. Two ﬂasks were
supplemented with 100 ng/ml hr-BMP-2, and two ﬂasks
were with medium alone. After 2 weeks cells were
harvested for mRNA isolation and gene expression
analysis. Part of the control cells (untreated) were passaged
and cultured into monolayer or alginate P2 (Fig. 1).
ENCAPSULATION IN ALGINATE BEADS
The preparation of chondrocytes in alginate beads was
performed as described12, with slight modiﬁcations: chon-
drocytes at passage 1 (P1) were resuspended in 1.2% low
viscosity alginate solution (Sigma, Taufkirchen, Germany) at
a density of 5!105 cells/ml. Beads were formed by dis-
persing the alginate-cell suspension dropwise into a 102 mM
CaCl2 solution (Sigma, Taufkirchen, Germany) through a
22-gauge needle attached to a syringe. The beads were
swirled in the CaCl2 solution for 10 min to allow polymeri-
sation and then were washed twice in PBS before immersion
in DMEM/F12 (1:1) cell culture medium supplemented with
10% human serum. Chondrocytes encapsulated in alginate
beads were cultured 2 weeks in medium alone, or in
presence of 100 ng/ml r-BMP-2, respectively (Fig. 1).
SOLUBILIZATION OF ALGINATE BEADS
For chondrocyte recovery, culture medium was aspirated
and cells were washed twice with PBS. To dissolve alginate
beads, 5 mM EDTA in PBS (Roth, Karlsruhe, Germany)
were added. After incubation for 15e30 min at room
temperature, the solubilized alginate was removed by
centrifugation at 1000 RPM for 10 min. The cell pellet was
washed twice with PBS and used for RNA extraction.
GENE EXPRESSION ANALYSIS
The RNA was extracted from cells using the RNeasy Mini
Kit (Qiagen Inc.; Valencia, CA) according to the manufac-
turer’s instructions. Complementary DNA (cDNA) was
obtained by reverse transcription of 1 mg mRNA (BD
Clontech, Heidelberg, Germany) using oligo dT as primer.
Reverse transcription was performed in a 20 ml volume in
a gradient thermocycler PCR (Whatman Biometra; Go¨ttin-
gen, Germany). To investigate the expression of chondro-
cyte speciﬁc marker genes and inﬂammatory cytokines we
used a real-time quantitative PCR (Light Cycler; Roche,
Mannheim, Germany). Gene sequences were ampliﬁed
using speciﬁc target primers optimized for this method
(SearchLC; Heidelberg, Germany). The PCR was per-
formed with the Light Cycler FastStart DNA SybrGreen kit
(Roche, Mannheim, Germany) according to the protocol
provided. The cDNA copy numbers in the respective
561Osteoarthritis and Cartilage Vol. 12, No. 7Fig. 1. Chondrocyte culture methods. After cell isolation chondrocytes were expanded in monolayer for 7e10 days. At pre-conﬂuence cells
were passaged and either cultured in monolayer (P1-2D) or encapsulated in alginate beads (P1-3D). Both culture types had medium alone or
medium supplemented with 100 ng/ml hr-BMP-2. After 2 weeks cells were harvested for gene expression analysis. Part of the P1-2D
chondrocytes were further passaged to establish P2 monolayer cultures as well as P2 alginate cultures with same culture conditions as at P1.samples were calculated from a standard curve obtained by
blotting known input concentrations to the PCR cycle
number (CP). The copy number was normalized by the
housekeeping gene glyceraldehyde-3-phosphate dehydro-
genase (GAPDH). To control the speciﬁcity of the ampliﬁ-
cation a melting curve analysis was performed. No
ampliﬁcation of unspeciﬁc products was observed.
IMMUNOCYTOCHEMISTRY AND ELISA
Alginate beads were ﬁxed using 4% paraformaldehyde,
washed with PBS and embedded in OCT compound
(Sakura; Zoeterwoude, Netherlands). Sections (7 mm) were
cut at 22(C on a Jung Frigocut 2800E cryostat and
mounted on Superfrost plus glass microscope slides (Erie
Scientiﬁc Company; Portsmouth, Netherlands). Sections
were dried for 1 h and stored at 20(C until further use.
Each step for the immunolabelling was performed at room
temperature. After thawing, non-speciﬁc staining was
blocked by incubation of the sections with 1% bovine
serum albumin (Sigma; St. Louis, USA) for 30 min. Sections
were incubated for 4 h with a monoclonal antibody against
collagen type II (clone II-II6B3, Developmental Studies
Hybridoma Bank, University of Iowa). Sections were then
incubated for 2 h with a Cy3-coupled goat anti-mouse
secondary antibody (Dianova; Hamburg, Germany). Exten-
sive washing with PBS was performed between each step.
All sections were counterstained with DAPI and mounted
with mowiol. Negative controls were obtained by omitting
incubation with the primary antibody.
The expression of type II collagen was also investigated
by ELISA using the native type II collagen detection kit
(Chondrex Inc., Redmond, USA). Brieﬂy, collagen was
digested by 10 mg/ml pepsin dissolved in 0.05 M acetic
acid overnight at 4(C with gentle mixing. Cells were then
incubated at 35(C for 30 min with 1 mg/ml pancreatic
elastase after that samples were centrifuged and super-
natants were diluted with the standard dilution buffer
provided by the kit. The ELISA plate was coated withcollagen type II antibody as described by the supplier,
100 ml/well of sample were added and incubated for 2 h at
room temperature. After washing samples were incubated
with streptavidin peroxidase-labeled detection reagent (di-
lution 1:200) for 1 h at room temperature. Finally, after
rinsing plates, color reaction followed though H2O2 in-
cubation for 30 min at room temperature, reaction was
stopped with 2.5 N sulfuric acid and the OD was read at
490 nm in an ELISA reader (Bio-Tek, KC 4 PowerWavex,
BioRad, Munich, Germany).
EXPRESSION AND PURIFICATION OF RECOMBINANT HUMAN BMP-2
Recombinant human BMP-2 was expressed in Escher-
ichia coli based on a maltose-binding protein (MBP)-fusion
expression vector. The malE fusion vector was constructed
from pMAL-c2X (New England Biolabs, Beverly, MA) by
removing the factor Xa site with an AvaIeBamHI restriction
digest and replacing them with an annealed pair of synthetic
oligonucleotides (5#-GTC CCT CGG GCA TCA CCA TCA
CCA TCA TTC TGG TCT GGT ACC ACG CGG ATC CGC
GC-3#, 5#-GCG CGG ATC CGC GTG GTA CCA GAC CAG
AAT GAT GGT GAT GGT GAT GCC CGA GGG AC-3#)
which were digested with the same restriction enzymes and
encode for a 6!His tag and a thrombin-binding site
(LVPRGS). A gene encoding for the mature human BMP-
2 was synthesized as BamHIeHindIII fragment (GENEART,
Regensburg, Germany) and cloned into the BamHIeHindIII
digested vector. IPTG induction of transformed E. coli cells
which were cultivated in a glucose mineral salt medium
results in cytoplasmic overexpression of soluble MBP-
fusion. Monomeric MBPeBMP-2 fusion protein was isolated
after cell disruption by amylose afﬁnity chromatography and
r-BMP-2 was puriﬁed to homogeneity after in vitro di-
merization of the BMP-2 still fused to MBP and protease
cleavage of the fusion as described earlier 13.
The mature r-BMP-2 homodimer, generated by the pro-
teolytic removal of the MBP domains, migrates as an ap-
proximately 26 kDa protein under non-reducing conditions
562 T. Gru¨nder et al.: BMP-2 enhancement studiesand as a 13 kDa protein under reducing conditions in
SDS-PAGE and has a purityO95%. NH2-terminal amino
acid sequence analysis of the puriﬁed BMP-2 reveals
the expected single main sequence corresponding to
GSQAKHKQRK.
Endotoxin contamination was !0.02 ng/mg of rh-BMP-2
as determined by the chromogenic kinetic method of the
limulus amoebocyte lysate (LAL) assay (Kinetic-QCL-kit,
BioWhittaker). Biological activity of the ﬁnal product was
measured by its ability to induce alkaline phosphatase
expression in mouse C2C12 promyoblast cells 14. The ED50
for this effect was found in the range of 20e40 nM and is in
good agreement with data from literature15.
STATISTICAL ANALYSIS
All data reported represent the median valueGrange (min
and max values) of individual analyses of eleven separate
donors. A student’s t test was performed to compare
monolayer vs alginate cultures and to assess the effect of
application of r-BMP-2 to monolayer and alginate cultures.
Results
GENE EXPRESSION DIFFERENCES IN CHONDROCYTES FROM
DISTINCT DONORS
In the present study we used chondrocytes from 11
individuals. All cartilage biopsies were harvested from low-
weight bearing and macroscopically healthy areas of the
femoral condyle. The culture protocol was identical for all
experiments. Nevertheless, the expression levels of mRNA
of several differentiation markers including type II collagen,
aggrecan, BMP-2 or IL-1b differed considerably between
the individual donors (see Table I) and seem not be related
either to gender or age.
EFFECT OF THE CULTURE SYSTEM ON THE CHONDROGENIC
PHENOTYPE
Freshly isolated human chondrocytes were ﬁrst expand-
ed in monolayer for 7e10 days to reach conﬂuence. One
aliquot of the cells was used to investigate the transcript
levels of these primary culture cells (P0). Remaining cells
were split and further cultured in monolayer or embedded inalginate beads (see Fig. 1 for cell culture scheme): one
aliquot was seeded in cell culture ﬂasks to further expand
the cells for 2 weeks in a ﬁrst subculture (P1-2D). The third
aliquot of cells was seeded in alginate beads and cultured
for 2 weeks (P1-3D). Then cells were harvested and gene
expression patterns were investigated by quantitative RT-
PCR (Fig. 2). The mRNA levels of alginate cultures are
reported relative to that of monolayers.
At P1 the expression of type I collagen signiﬁcantly
decreased in chondrocytes cultured in alginate (P1-3D)
compared to cells in monolayer (P1-2D, P!0:001). Tran-
scripts encoding type II collagen increased in 10 of 11
donors (mean increase: 115-fold; max: 643-fold; min: 1.6-
fold) when cells were cultured in alginate. However, in cells
from one donor the type II collagen level was not affected by
the culture system. The tendency of chondrocytes to
produce more type II collagen in 3D cultures compared to
monolayer cultures was also conﬁrmed by immunocyto-
chemistry using an antibody speciﬁc for collagen type II
(Fig. 3). The type II collagen staining is stronger in cells
embedded in alginate when compared to cells grown as
monolayer [Fig. 3(AeC)] and an almost 10-fold increase in
type II collagen synthesis was recorded by ELISA in
samples of 3D cultures in comparison to monolayer cultures
[n ¼ 4, 9.45-foldG6.8, P!0:043; Fig. 3(D)]. Interestingly, in
all donors the transcript levels for BMP-2, a chondrogenic
marker, were higher in alginate cultures compared to
monolayers. In contrast, the expression of BMP-4 (11/11,
P!0:001) and IL-18 (10/11, P!0:05) were signiﬁcantly
lower in 3D cultures. The culture system had no effect on
the expression of aggrecan, IL-1b or IL-10 (Fig. 2).
In a second experiment cells were embedded in alginate
after a ﬁrst subculture on monolayer. Transcript levels
obtained for P2 alginate were expressed relative to that
obtained for P2 monolayer (Fig. 4). Again, the expression of
type I collagen was reduced in all alginate cultures in
comparison to P2 monolayer cultures (P!0:01) and the
transcripts for type II collagen were up-regulated in all
donors. The mean increase was of 1000-fold (max: 3120-
fold; min: 5-fold). Considerable differences in the magnitude
of type II collagen mRNA increases were observed between
distinct donors. In two cases we cultured the cells in
alginate until P3, to investigate if the expression of type II
collagen was further up-regulated in 3D cultures (Fig. 5).
The increased amplitude seemed to depend on the original
expression level in the primary culture: at P3-3D theTable I
mRNA expression levels relative to the housekeeping gene GAPDH for chondrocytes from 11 donors in primary culture. Considerable
differences in the gene expression are present between the five donors, but they seemed not to be related neither to gender, nor to age
Gender Age mRNA expression levels in primary cultures
Collagen type II Collagen type I Aggrecan BMP-2 IL-1b
Donor 1 M 19 1498.4 96539.7 17834.6 38.4 7.9
Donor 2 M 27 15.3 78175.2 21806.6 621.7 1.4
Donor 3 M 30 189.4 165097.1 14123.6 22.9 0.3
Donor 4 F 20 131.8 139610.0 13294.5 278.8 4.6
Donor 5 F 23 5822.5 413536.9 32592.3 233.3 0.1
Donor 6 F 31 512.7 172027.0 20792.1 2 599.0 0.1
Donor 7 M 38 1042.0 137944.0 12672.0 1 555.0 0.1
Donor 8 F 71 1294.0 161481.0 17232.0 2 269.0 0.1
Donor 9 M 32 217.9 179076.0 29317.3 14.6 2.1
Donor 10 M 77 37297.1 56978.7 73141.0 24 462.9 1.1
Donor 11 M 70 15774.5 96153.9 40693.0 971.9 1.3
563Osteoarthritis and Cartilage Vol. 12, No. 7Fig. 2. Effect of culture conditions on matrix protein and cytokine gene expression in ﬁrst subcultures of human articular chondrocytes.
Chondrocytes from each donor were cultured individually in monolayer and in alginate beads for 2 weeks. The transcript levels in alginate
cultures are expressed relative to that of monolayers. The mRNA levels for all genes were normalized with the amount of the housekeeping
gene GAPDH. Values indicate the median result of ﬁve experiments; deviations are represented by the range between the minimal and the
maximal values observed. Statistical signiﬁcance is given as follows:***P!0:001; *P!0:05.cells re-expressed the same amount of collagen type II as
at P0.
The inﬂuence of culture system at P2 on the other
transcripts was similar to that observed at P1. BMP-2 was
mRNA up-regulated in all cases and transcripts encoding
BMP-4 and IL-18 were signiﬁcantly down-regulated in
alginate cultures (P!0:001 and P!0:05, respectively).
The expression of IL-18 is high in primary cultures, de-
creased during different passages in monolayer and re-
mained low in alginate. Similar to what was seen at P1, IL-1b
and aggrecan were not inﬂuenced by the culture system.EFFECT OF RH-BMP-2 ON THE CHONDROGENIC PHENOTYPE
IN DIFFERENT CULTURE SYSTEMS
Next, chondrocytes were expanded in 2D and 3D cul-
tures in absence or presence of 100 ng/ml hr-BMP-2 on
monolayers [Fig. 6(A)] and on alginate cultures [Fig. 6(B)].
Incubation of chondrocytes in 2D culture in presence hr-
BMP-2 did not change the transcript patterns sizably for
most genes when compared to untreated controls [Fig.
6(A)]. In 8/11 samples application of hr-BMP-2 induced
a slight increase of the type II collagen transcript amounts
(mean: 11.3-fold; max: 76.7-fold; min: 1.3-fold, P!0:04).Fig. 3. Immunocytochemical localization of collagen type II in primary cultures. (A) Collagen type II staining in monolayers. (B) Collagen type II
staining in cells embedded in alginate beads. (C) Negative control of alginate culture obtained by omitting the primary antibody. All slides were
counterstained with DAPI. Original magniﬁcation: !40. (D) Detection of type II collagen expression by ELISA in chondrocytes embedded in
alginate beads compared to cells grown in monolayer cultures (n ¼ 4; *P!0;05).
564 T. Gru¨nder et al.: BMP-2 enhancement studiesFig. 4. Effect of culture conditions on matrix protein and cytokine gene expression in second subcultures of human articular chondrocytes. The
transcript levels in alginate P2 cultures are expressed relative to that of P2 monolayers. The mRNA levels for all genes were normalized with
the amount of the housekeeping gene GAPDH. Values indicate the median result of ﬁve experiments; deviations are represented by the range
between the minimal and the maximal values observed. Statistical signiﬁcance is given as follows: ***P!0:001; **P!0:01; *P!0:05.A more prominent effect was seen when cells were
encapsulated in alginate beads in presence of 100 ng/ml hr-
BMP-2 [Fig. 6(B)]. The hr-BMP-2 induced a signiﬁcant
increase in type II collagen encoding mRNA in [8/10
samples, mean: 256-fold; max: 1350-fold; min: 1.2-fold,
P!0:05; Fig. 6(B)]. An enhanced type II collagen expres-
sion was also noted by ELISA [Fig. 6(C)]. Addition of BMP-2
to chondrocytes in alginate beads almost doubled in 3/4
samples the type II collagen expression (11.94-foldG8.57)
when compared to the respective 3D controls [5.27-foldG
5.7; Fig. 6(C)]. In one sample, addition of BMP-2 did not
enhance type II collagen expression (data not shown).
Human r-BMP-2 had no effect on the collagen type II protein
level in monolayer.
In contrast to 2D cultures, in 3D cultures hr-BMP-2
signiﬁcantly reduced IL-1b encoding mRNA amounts [10/
10, mean: 0.63-fold; min: 0.06; max: 1, P!0:003, Fig. 6(B)].
Moreover, aggrecan mRNA was signiﬁcantly up-regulated
through the application of hr-BMP-2 in alginate cultures (9/
10 samples; mean: 3.2-fold; max: 9-fold; min: 1-fold).
Similar to what was observed in monolayers, r-BMP-2
seemed not to inﬂuence the transcript levels encoding type I
collagen, BMP-2 and BMP-4, IL-18 and IL-10.Discussion
Cartilage stabilization and repair constitute a major
challenge in joint diseases. Autologous chondrocyte trans-
plantation (ACT) is a promising technique for repair of large
cartilage defects in joints. The experience shows, that the
quality of the cells implanted into the defect is of central
importance for the therapeutic success of ACT6. The
chondrogenic phenotype must be preserved during the
period of in vitro cell expansion. Seeding cells in alginate
beads supports chondrogenesis and maintains a chondro-
genic phenotype of the cells. In beads chondrocytes syn-
thesize cartilage matrix components similar to those present
in the native tissue8,16. In addition, there is good evidence
that alginate possesses the physical characteristics and
handling properties required to support cells and serve as
a carrier for treatment of full-thickness defects in vivo17,18.
In the present study, two distinct cell culture systems and
a morphogen of the TGF-b family, BMP-2, were analysed
for their potential to maintain or enhance chondrocyte
differentiation and cartilage maturation in an artiﬁcial model
of human cartilage tissue engineering. In the ﬁrst part of this
study we examined the effect of the cell culture system onFig. 5. Recovery of collagen type II expression in alginate culture. Chondrocytes from two distinct human donors were analysed after 7e10
days of expansion in monolayer as primary cultures (P0) and after incubation in alginate beads (3D) for 2 weeks in P1, P2 or P3. A progressive
recovery of the type II collagen expression was observed. At P3 the expression levels reached those observed in the primary culture. The
mRNA levels for type II collagen were normalized with the amounts of housekeeping gene GAPDH.
565Osteoarthritis and Cartilage Vol. 12, No. 7Fig. 6. Effect of hr-BMP-2 on matrix protein and cytokine gene expression in ﬁrst subcultures of human articular chondrocytes The mRNA
levels of cells in presence of 100 ng/ml BMP-2 in monolayer (A) or alginate bead cultures (B) are expressed relative to that of control cells
without BMP-2. The mRNA levels for all genes were normalized with the amount of the housekeeping gene GAPDH. Values indicate the
median result of four experiments; deviations are represented by the range between the minimal and the maximal values observed. Statistical
signiﬁcance is given as follows: **P!0:01; *P!0:05. The type II collagen expression at the protein level in 2D vs 3D cultures in absence or
presence of 100 ng/ml hr-BMP-2 was investigated by ELISA (C). The data represent the median collagen induction index (n ¼ 3 samples)
normalized to 2D chondrocytes without hr-BMP-2.the chondrogenic phenotype. We found that when P1
chondrocytes from healthy human donors were cultured in
alginate beads, phenotype markers for cartilage, such as
type II collagen and BMP-2, were signiﬁcantly up-regulated
while the expression of type I collagen was signiﬁcantly
down-regulated when compared to monolayer cultures. The
maintenance of the chondrogenic phenotype was also
preserved in cells which were passaged twice, before being
encapsulated in alginate beads. Interestingly, the alginate
system signiﬁcantly decreased the expression of IL-18 in
P1 and P2 chondrocytes. This inﬂammatory cytokine has
been shown to have similar but milder effects as IL-1b. In
vitro IL-18 can reduce the chondrocytes proliferation rate,
which would represent a problem when expanding cells for
tissue engineering or transplantation. In addition, IL-18 may
contribute to the degradation of cartilage extracellular matrix
by inducing stromelysin and by stimulating the production ofNO-radicals 19,20. Our results corroborate previous work
7,8,21e23, indicating that alginate is an interesting culture
system to maintain chondrocytes in a differentiated stage or
to induce a process of re-differentiation. However, growth of
cells in alginate alonemay not be sufﬁcient for cell expansion
for the purpose of tissue engineering, therapeutic cell culture
or medical cartilage repair, because of their very low
proliferation rate when embedded in alginate beads24.
Chondrocytes were expanded in monolayer cultures or
embedded in alginate in presence or absence of 100 ng/ml
hr-BMP-2. The potential clinical uses of proteins from the
TGF-b family in treating bone and cartilage defects have
stimulated extensive research25e27. In addition, BMP-2 has
been shown to play a role in the regulation of cartilage-
related genes27,28. In contrast to previous reports28, we
could not observe a signiﬁcant improvement of the
chondrogenic phenotype through application of 100 ng/ml
566 T. Gru¨nder et al.: BMP-2 enhancement studieshr-BMP-2 on chondrocytes expanded in monolayer culture.
One possible explanation could be that human chondro-
cytes grown under Good Manufacturing Practice (GMP)
conditions suitable for ACT in monolayer are not responsive
to BMP-2. In contrast, chondrocytes of other species such
as the equine chondrocytes used in those studies and
expanded under experimental conditions including xenobi-
otic serum28 may react differently.
In comparison to the 2D cultures, the situation changed
when cells were cultured three-dimensionally in the
presence of hr-BMP-2: the quality of the cells was still
increased compared to control alginate cultures. Application
of hr-BMP-2 on alginate cultures induced a statistically
signiﬁcant increase of the collagen type II expression
(P%0:05) as well as a signiﬁcant increase in the aggrecan
expression (P%0:01). This effect might be explained by
ionic interactions between the basic residues in the heparin-
binding site of hr-BMP-2 and carboxylate groups of alginic
acid which contribute to a restricted diffusion of the BMP29.
In conclusion, our results indicate that alginate encapsu-
lation is efﬁcient not only in causing the re-expression or
maintenance of chondrogenic markers in passaged human
chondrocytes and in reducing the expression levels of
dedifferentiation markers, but it also represents an in-
teresting cell culture model because of its increased
responsiveness of human chondrocytes to growth factor
BMP-2. This could be of tremendous use for tissue
engineering purposes. In addition, alginate has a major
advantage over most other systems in that the cells can be
recovered easily in a healthy state by simply dissolving the
calcium alginate gel with chelating agents. It is even
imaginable to think about implanting alginate constructs
directly into a cartilage defect. Such experiments were
already performed in mice17 and in rabbits18 resulting in
a good cartilage formation. However, as our data do not
corroborate results obtained with animal cells18, the use of
alginate as scaffold for ACT in humans must be considered
with outmost care. Further, it is still unclear, whether
alginate-augmented cartilage tissue could induce immune
reactions in vivo as discussed recently30.
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